Abstract
Background: Alcohol hangover is a common occurrence among individuals who have experienced an episode of heavy alcohol consumption the previous night. Until now defined as the general feeling of misery that develops once the Blood Alcohol Concentration approaches zero. Despite its prevalence and several related adverse consequences, insufficient research has been conducted with regards to this matter and further understanding of the pathology of alcohol hangover is necessary. During the 9th Alcohol Hangover Research Group meeting, held on April 29th 2017, Utrecht, The Netherlands, numerous aspects of alcohol hangover were presented and many advances with regards to determinants, biological and cognitive consequences and potential treatment have been presented. Conclusion: Precisely, a definition of alcohol hangover has been established and wider understandings of biological and cognitive effects, alcohol metabolism, immune functioning and potential treatment of alcohol hangover were presented and discussed. Further research and development are necessary to attain a wider understanding of the pathology of alcohol hangover.
Original language | English |
---|---|
Pages (from-to) | 68-75 |
Number of pages | 8 |
Journal | Current Drug Abuse Reviews |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2017 |
Funding
Sarah Benson has received funding from Red Bull GmbH. Jacqueline Iversen is the Head of Clinical Development of Sen-Jam Pharmaceutical. Sean Johnson has undertaken sponsored research for Pfizer, AstraZeneca, Merck, Gilead, Novartis, Roche, Red Bull GmbH, The Department for Transport, and Road Safety Trust. Andrew Scholey has held research grants from Abbott Nutriton, Arla Foods, Bayer Healthcare, Cognis, Cyvex, GlaxoSmithKline, Naturex, Nestlé, Martek, Masterfoods, Wrigley, and has acted as a consultant/expert advisor to Abbott Nutrition, Barilla, Bayer Healthcare, Danone, Flordis, GlaxoSmithKline Healthcare, Masterfoods, Martek, Novartis, Unilever, and Wrigley. Joris Verster has received grants/research support from the Dutch Ministry of Infrastructure and the Environment, Janssen Research and Development, Nutricia, Red Bull, Sequential, and Takeda, and has acted as a consultant for the Canadian Beverage Association, Centraal Bureau Drogisterijbedrijven, Coleman Frost, Danone, Deenox, Eisai, Janssen, Jazz, Purdue, Red Bull, Sanofi-Aventis, Sen-Jam Pharmaceutical, Sepracor, Takeda, Transcept, Trimbos Institute, and Vital Beverages. The other authors have no potential conflicts of interest to disclose.
Keywords
- Alcohol
- Definition
- Ethanol
- Hangover
- Metabolism
- Resistance
- Treatment